Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Fannin (UK) Limited, 42-46 Booth Drive, Park Farm South, Wellingborough, Northamptonshire, NN8 6GT
Nabumetone 500 mg Tablets.
Pharmaceutical Form |
---|
Film-coated tablet. Brown, capsule-shaped biconvex tablet marked ‘NEO’ on one side ‘NBU500’ on the other. |
Nabumetone 500 mg.
For a full list of excipients see section 6.1.
Active Ingredient | Description | |
---|---|---|
Nabumetone |
Nabumetone is a non acidic non steroidal anti-inflammatory agent with weak prostaglandin synthesis properties. Nabumetone undergoes rapid and extensive metabolism in the liver to 6-methoxy-2-naphthylacetic acid (6-MNA), the principal active metabolite which is a potent inhibitor of prostaglandin synthesis. |
List of Excipients |
---|
Maize starch Film Coating: Hypromellose |
Blisters of PVC/PVdC/aluminium.
Pack sizes of 8, 56 and 100 tablets.
Fannin (UK) Limited, 42-46 Booth Drive, Park Farm South, Wellingborough, Northamptonshire, NN8 6GT
PL 20417/0054
8 January 2004/13 January 2012
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.